The 2 most recent market catalysts affecting $ADXN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 25, 2026
Corporate Catalyst
Bullish
Impact 75
Addex Therapeutics shares are trading higher after the company announced it regained full global rights to all GABAB positive allosteric modulator assets discovered under its research collaboration with Indivior UK.
This headline is a significant corporate catalyst for Addex Therapeutics, as regaining full global rights to GABAB positive allosteric modulator assets provides them with complete …
Aug 26, 2026
Corporate Catalyst
Bullish
Impact 65
Addex Therapeutics Raises $2.8M Gross Proceeds Through ATM Sale Of 437,869 ADSs, Extends Cash Runway To Q4 2027
This headline indicates a common strategy for small-cap biotech companies: raising capital through an At-The-Market (ATM) offering. While the $2.8 million is a relatively small amo…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.